莱普降低了葡萄糖生成和葡萄糖生成基质的可用性在患有脂质营养不良的患者
Emmanuel Quaye1, Shaji Chacko2, Megan Startzell1
1National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
The Journal of clinical endocrinology and metabolism
|July 29, 2023
概括
再组合勒丁 (metreleptin) 治疗通过减少葡萄糖生成 (GNG) 关键基质,降低了脂质变性患者的葡萄糖产量. 这突出了勒素的作用.
科学领域:
- 内分泌学 在内分泌学.
- 代谢疾病 代谢疾病
- 脂质代谢 脂质代谢是什么
背景情况:
- 瘦素缺乏,正如在脂质营养不良中所见,会损害能量平衡.
- 在这些患者中,重组瘦素 (metreleptin) 治疗改善了血糖控制,并减少了能量消耗.
- 该机制可能涉及减少葡萄糖生成 (GNG),这是一个能源密集的过程.
研究的目的:
- 为了研究甲列列平素对GNG及其基质在脂质变中的影响.
- 为了确定甲列普丁是否改变了GNG及其前体的可用性.
主要方法:
- 对15名接受metreleptin治疗的脂质缩症患者进行前性研究.
- 对GNG,胰岛素敏感性和GNG基质 (甘油,棕酸盐,氨酸,乳酸盐) 的分析.
- 评估包括HbA1c和禁食胰岛素在内的血糖标志物.
主要成果:
- 梅特利普丁降低了基底GNG,并增强了GNG的胰岛素抑制.
- 治疗改善了胰岛素敏感性和血糖控制标志物.
- 梅特利普丁降低了GNG基质,如氨酸,乳酸和糖醇;棕酸盐的贡献也减少了.
结论:
- 梅特利普丁通过限制基质可用性来降低脂质变质症中的GNG.
- 氨酸仍然是一致的GNG基质,与甘油和棕酸盐不同,表明治疗后脂解影响减少.
相关概念视频
Overview of Lipid Metabolism
1.8K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.8K
Glucagon-like Receptor Agonists
358
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
358
Hypoglycemia and Glucagon
301
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
301
Metabolic States of the Body: Fasting and Starvation
1.5K
During the initial hours of fasting, the body uses up its glycogen stores as an energy source. Once these glycogen reserves are depleted, the body begins breaking down stored triglycerides and structural proteins. During this stage, glycerol becomes a key substrate for gluconeogenesis, while free fatty acids undergo beta-oxidation to provide energy for tissues, such as skeletal muscle. In the fasting state, the body spares protein breakdown as much as possible to conserve muscle and structural...
1.5K
Hormones Regulating Blood Glucose
3.5K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
3.5K
Metabolic States of the Body: The Postabsorptive State
368
The postabsorptive state usually starts about four hours after a meal and lasts until the next meal is eaten. During this time, the digestive system stops absorbing nutrients, and the body uses stored energy reserves to maintain stable blood glucose levels.
Initially, glycogen stored in the liver is broken down to release glucose into the bloodstream, while glycogen in the muscles is broken down to supply glucose for energy directly within the muscle cells. As glycogen stores diminish,...
Initially, glycogen stored in the liver is broken down to release glucose into the bloodstream, while glycogen in the muscles is broken down to supply glucose for energy directly within the muscle cells. As glycogen stores diminish,...
368


